Scientists at the Skaggs School of Pharmacy and Pharmaceutical Sciences in California have made progress in the field of synthetic DNA. The researchers have shown that cells can recognize and use synthetic nucleotides to produce proteins. This discovery has potential applications in designing unique proteins and developing new medications. The study focuses on a new version of the genetic alphabet called AEGIS, which incorporates two new base pairs. These synthetic base pairs have a similar structure to natural base pairs, allowing them to be incorporated into the transcription process.
Scientists at the Skaggs School of Pharmacy and Pharmaceutical Sciences in California have made progress in the field of synthetic DNA. The researchers have shown that cells can recognize and use synthetic nucleotides to produce proteins. This discovery has potential applications in designing unique proteins and developing new medications. The study focuses on a new version of the genetic alphabet called AEGIS, which incorporates two new base pairs. These synthetic base pairs have a similar structure to natural base pairs, allowing them to be incorporated into the transcription process.
We use cookies to improve your experience on our site and to show you relevant advertising. To find out more, read our updated privacy policy and cookie policy
Through RSS Feeds 
Scientists at the Skaggs School of Pharmacy and Pharmaceutical Sciences in California have made progress in the field of synthetic DNA. The researchers have shown that cells can recognize and use synthetic nucleotides to produce proteins. This discovery has potential applications in designing unique proteins and developing new medications. The study focuses on a new version of the genetic alphabet called AEGIS, which incorporates two new base pairs. These synthetic base pairs have a similar structure to natural base pairs, allowing them to be incorporated into the transcription process. 
